Cerity Partners LLC Uro Gen Pharma Ltd. Transaction History

Cerity Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.81 - $19.33 $1.22 Million - $1.71 Million	-88,261 Reduced 70.48%	36,965 $554,000
Q4 2023 Jan 26, 2024	BUY	$10.87 - $15.93 $1.36 Million - $1.99 Million	125,226 New	125,226 $1.88 Million
Q2 2022 Aug 10, 2022	SELL	$5.12 - $8.74 $15,508 - $26,473	-3,029 Reduced 2.36%	125,226 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$9.03 - $19.13 $1.07 Million - $2.26 Million	118,214 Added 1177.31%	128,255 $1.22 Million
Q1 2021 Aug 11, 2021	BUY	$17.99 - $26.96 $180,637 - $270,705	10,041 New	10,041 $196,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.